Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000895345-25-000365
Filing Date
2025-11-21
Accepted
2025-11-21 19:27:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 5482
  Complete submission text file 0000895345-25-000365.txt   7020
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Filed by) CIK: 0001315797 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650) 822-5500
Annexon, Inc. (Subject) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91583 | Film No.: 251509344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)